Keyphrases
Acute Myeloid Leukemia
100%
Interleukin-2
100%
Adult Patients
100%
Complete Remission
100%
First Complete Remission
100%
Leukemia Patients
14%
Continuous Infusion
14%
Hematological Diseases
14%
Chemotherapy
7%
Natural Killer Cells
7%
Immunomodulatory Effect
7%
Median Survival
7%
Therapeutic Strategies
7%
Treatment Initiation
7%
Remission
7%
Chromosome 11
7%
Bolus
7%
Consolidation Chemotherapy
7%
Cytotoxic T Cells
7%
Normal Karyotype
7%
Cytogenetic Abnormalities
7%
Post-remission Chemotherapy
7%
Lymphokine-activated Killer Cells
7%
Inv(16)
7%
Nursing and Health Professions
Pilot Study
100%
Remission
100%
Acute Myeloid Leukemia
100%
Interleukin 2
100%
Continuous Infusion
11%
Disease
11%
Consolidation Chemotherapy
5%
Lymphokine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Remission
100%
Acute Myeloid Leukemia
100%
Interleukin 2
100%
Chemotherapy
16%
Disease
11%
Lymphokine
5%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Interleukin 2
100%
Chemotherapy
20%
Continuous Infusion
20%
Blood Disorder
20%
Chromosome 11
10%
Consolidation Chemotherapy
10%
Lymphokine Activated Killer Cell
10%
Cytotoxic T-Cell
10%
Natural Killer Cell
10%
Karyotype
10%
Neuroscience
Interleukin 2
100%
Cytogenetics
20%
Chromosome 11
10%
Lymphokine
10%
T Cell
10%
Natural Killer Cell
10%
Karyotype
10%
Immunology and Microbiology
Interleukin 2
100%
Cytotoxic T Cell
10%
Natural Killer Cell
10%
Chromosome 11
10%
Lymphokine Activated Killer Cell
10%
Karyotype
10%